Related Experiment Video
Updated: Jun 17, 2026

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
Published on: February 1, 2017
Hepatitis B virus infection in hemodialysis populations: progress toward prevention
Katherine A Barraclough1, E Geoffrey Playford
1Department of Nephrology, University of Queensland, Princess Alexandra Hospital, Brisbane, Australia. katherine_barraclough@health.qld.gov.au
Abstract:
Hemodialysis patients are at increased risk of acquiring hepatitis B virus (HBV) infection. Administration of the standard HBV vaccine is suboptimal as a means of prevention because of an impaired seroconversion response in individuals with chronic kidney disease. Surquin and colleagues describe a novel vaccine adjuvant system that increases speed of seroconversion and duration of seroprotection compared with older vaccine formulations. However, its ability to improve overall seroconversion response remains unproven.
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction
Hemodialysis I: Introduction
Hemodialysis II: Procedure and Complications
Hemodialysis III: Nursing Management
Acute Kidney Injury IV: Diagnostic Studies and Prevention
